Investing

Wednesday's Top Analyst Upgrades and Downgrades: Amgen, ADM, Eli Lilly, Home Depot, Medtronic, Palantir, Snowflake, Take-Two Interactive, Walgreens and More

BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN): Truist Financial reiterated a Buy rating with a $133 target price. The consensus target is $113.90. The stock closed on Tuesday at $81.25.

Delek US Holdings Inc. (NYSE: DK): Scotiabank upgraded the stock to Sector Perform from Sector Underperform and has a $35 price objective. The consensus target is $33.33. Tuesday’s close was at $33.43.

Eli Lilly and Co. (NYSE: LLY): Goldman Sachs raised its $281 price target to $313 while maintaining a Neutral rating. The stock hit a new 52-week high of $368.75 on Tuesday and closed at $366.66.

Energy Recovery Inc. (NASDAQ: ERII): Raymond James lifted its Market Perform rating to Outperform with a $23 target. The consensus target is $27.00. The shares closed 7% higher on Tuesday at $20.02 on no news we could source.

Estee Lauder Companies Inc. (NYSE: EL): The Zacks Bear of the Day stock is widely underperforming the general market, points out the analyst. Shares have traded as high as $374.20 apiece in the past year but closed most recently at $207.89. That is down about 23% in the past 90 days.

Freshpet Inc. (NASDAQ: FRPT): Oppenheimer reiterated an Outperform rating and has an $80 target price. The consensus target is $69.12. The last trade for Tuesday hit the tape at $67.82.

Home Depot Inc. (NYSE: HD): Goldman Sachs lowered its $366 price target on the Buy-rated stock to $329, less than the $349.45 consensus target. The stock closed on Tuesday at $291.14.

IAA Inc. (NYSE: IAA): Jefferies downgraded the stock to Hold from Buy. Its $40 target price is lower than the $50.13 consensus target. The stock closed on Tuesday at $38.14.

Lending Tree Inc. (NASDAQ: TREE): Oppenheimer lowered its $55 price target to $35 while keeping an Outperform rating. The consensus target is $41.89. Tuesday’s close at $24.79 was up over 3% for the day.


Marsh & McLennan Companies Inc. (NYSE: MMC): Atlantic Equities downgraded the stock to Neutral from Overweight, but its $185 price target is higher than the $173.93 consensus target. The stock closed on Tuesday at $161.73.

Medtronic PLC (NYSE: MDT): Stifel reiterated a Buy rating with a $105 target price. The posted consensus target is $105.05, and shares were last seen at $80.19, after retreating over 6% on Tuesday as one of its devices failed on primary goals.

Palantir Technologies Inc. (NYSE: PLTR): Goldman Sachs lowered its price target on the Neutral-rated stock to $9 from $10. The consensus target is $9.98. Tuesday’s close was at $7.21.

Q2 Holdings Inc. (NYSE: QTWO): Piper Sandler’s downgrade to Underweight from Neutral included a target price cut from $45 to $22. The consensus target is $59.75 for now. The stock closed on Tuesday at $24.40, which was down almost 8% on the day despite beating earnings estimates.

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.